These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 3957488)

  • 61. The metabolism of nifedipine during long-term therapy.
    Snedden W; Fernandez PG; Nath C
    Clin Invest Med; 1986 Nov; 9(4):244-9. PubMed ID: 3802611
    [TBL] [Abstract][Full Text] [Related]  

  • 62. On the interaction between phenytoin and digoxin.
    Rameis H
    Eur J Clin Pharmacol; 1985; 29(1):49-53. PubMed ID: 4054206
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Effect of alprazolam on digoxin kinetics and creatinine clearance.
    Ochs HR; Greenblatt DJ; Verburg-Ochs B
    Clin Pharmacol Ther; 1985 Nov; 38(5):595-8. PubMed ID: 2865030
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Pharmacokinetic aspects of digoxin in patients with terminal renal failure. IV. Clinical implications of own observations with a recent review of literature.
    van der Vijgh WJ; Oe PL
    Int J Clin Pharmacol Biopharm; 1978 Nov; 16(11):540-6. PubMed ID: 730421
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Bioavailability and elimination of various digoxin preparations in the beagle dog and their possible sex dependence (author's transl)].
    Gastauer R; Eltze M; Pabst J
    Arzneimittelforschung; 1979; 29(5):754-7. PubMed ID: 582973
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The long-term effect of verapamil on plasma digoxin concentration and renal digoxin clearance in healthy subjects.
    Pedersen KE; Dorph-Pedersen A; Hvidt S; Klitgaard NA; Pedersen KK
    Eur J Clin Pharmacol; 1982; 22(2):123-7. PubMed ID: 7094982
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The effect of nifedipine on serum digoxin concentrations in patients.
    Schwartz JB; Raizner A; Akers S
    Am Heart J; 1984 Apr; 107(4):669-73. PubMed ID: 6702561
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Digoxin pharmacokinetics: role of renal failure in dosage regimen design.
    Koup JR; Jusko WJ; Elwood CM; Kohli RK
    Clin Pharmacol Ther; 1975 Jul; 18(1):9-21. PubMed ID: 1149366
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Effects of nifedipine and diltiazem on plasma levels and renal excretion of beta-acetyldigoxin.
    Kuhlmann J
    Clin Pharmacol Ther; 1985 Feb; 37(2):150-6. PubMed ID: 3967458
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Interaction between digoxin and nifedipine at steady state in patients with atrial fibrillation.
    Kleinbloesem CH; van Brummelen P; Hillers J; Moolenaar AJ; Breimer DD
    Ther Drug Monit; 1985; 7(4):372-6. PubMed ID: 3909533
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Effect of quinine on plasma digoxin concentration and renal digoxin clearance.
    Pedersen KE; Lysgaard Madsen J; Klitgaard NA; Kjaer K; Hvidt S
    Acta Med Scand; 1985; 218(2):229-32. PubMed ID: 4061126
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Effects of diltiazem on plasma level and urinary excretion of digoxin in healthy subjects.
    Yoshida A; Fujita M; Kurosawa N; Nioka M; Shichinohe T; Arakawa M; Fukuda R; Owada E; Ito K
    Clin Pharmacol Ther; 1984 May; 35(5):681-5. PubMed ID: 6713780
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Digitoxin elimination in healthy subjects taking ampicillin.
    Lucena MI; Moreno A; Fernandez MC; Garcia-Morillas M; Andrade R
    Int J Clin Pharmacol Res; 1987; 7(1):33-7. PubMed ID: 3583486
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Digoxin in the elderly: pharmacokinetic consequences of old age.
    Cusack B; Kelly J; O'Malley K; Noel J; Lavan J; Horgan J
    Clin Pharmacol Ther; 1979 Jun; 25(6):772-6. PubMed ID: 445943
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Effect of quinine on digoxin kinetics.
    Wandell M; Powell JR; Hager WD; Fenster PE; Graves PE; Conrad KA; Goldman S
    Clin Pharmacol Ther; 1980 Oct; 28(4):425-30. PubMed ID: 7408402
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Effect of repeated low-dose organophosphorothionate pesticide exposure on digoxin pharmacokinetics in rats; a possible interaction involving p-glycoprotein.
    Cem KY; Kubilay O; Ozlem E; Hulya E; Ayse G
    Toxicol Mech Methods; 2007; 17(8):459-66. PubMed ID: 20020872
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Single- and multiple-dose kinetics of intravenous digoxin.
    Ochs HR; Greenblatt DJ; Bodem G
    Clin Pharmacol Ther; 1980 Sep; 28(3):340-5. PubMed ID: 7408393
    [TBL] [Abstract][Full Text] [Related]  

  • 78. The diltiazem-digoxin interaction.
    Rameis H; Magometschnigg D; Ganzinger U
    Clin Pharmacol Ther; 1984 Aug; 36(2):183-9. PubMed ID: 6744777
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Digoxin pharmacokinetics: multicompartmental analysis and its clinical implications.
    Sumner DJ; Russell AJ
    Br J Clin Pharmacol; 1976 Apr; 3(2):221-9. PubMed ID: 973956
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Pharmacokinetics of digoxin in patients subjected to the quinidine-digoxin interaction.
    Schenck-Gustafsson K; Dahlqvist R
    Br J Clin Pharmacol; 1981 Feb; 11(2):181-6. PubMed ID: 7213521
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.